Showing 1 - 5 results of 5 for search 'Zhongli Cai', query time: 0.05s Refine Results
  1. 1
    Auger electrons for cancer therapy - a review

    Auger electrons for cancer therapy - a review by Anthony Ku, Valerie J. Facca, Zhongli Cai, Raymond M. Reilly

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    [225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts

    [225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive... by Misaki Kondo, Zhongli Cai, Conrad Chan, Nubaira Forkan, Raymond M. Reilly

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape

    Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape by Raymond M. Reilly, Constantine J. Georgiou, Madeline K. Brown, Zhongli Cai

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu

    Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu by Sadaf Aghevlian, Zhongli Cai, David Hedley, Mitchell A. Winnik, Raymond M. Reilly

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Dose predictions for [177Lu]Lu-DOTA-panitumumab F(ab')2 in NRG mice with HNSCC patient-derived tumour xenografts based on [64Cu]Cu-DOTA-panitumumab F(ab')2 - implications for a PET theranostic strategy

    Dose predictions for [177Lu]Lu-DOTA-panitumumab F(ab')2 in NRG mice with HNSCC patient-derived tumour xenografts based on [64Cu]Cu-DOTA-panitumumab F(ab')2 - implications for a PET... by Anthony Ku, Misaki Kondo, Zhongli Cai, Jalna Meens, Min Rong Li, Laurie Ailles, Raymond M. Reilly

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: